These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 7813815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
    Mironova MA, Klein RL, Virella GT, Lopes-Virella MF.
    Diabetes; 2000 Jun; 49(6):1033-41. PubMed ID: 10866057
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
    Ahmed E, Trifunovic J, Stegmayr B, Hallmans G, Lefvert AK.
    Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
    [Abstract] [Full Text] [Related]

  • 10. The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.
    Orem A, Cimşit G, Değer O, Orem C, Vanizor B.
    Clin Chim Acta; 1999 Jun 15; 284(1):81-8. PubMed ID: 10437645
    [Abstract] [Full Text] [Related]

  • 11. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation.
    Seccia M, Albano E, Maggi E, Bellomo G.
    Arterioscler Thromb Vasc Biol; 1997 Jan 15; 17(1):134-40. PubMed ID: 9012648
    [Abstract] [Full Text] [Related]

  • 12. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls.
    Mironova M, Virella G, Virella-Lowell I, Lopes-Virella MF.
    Clin Immunol Immunopathol; 1997 Oct 15; 85(1):73-82. PubMed ID: 9325072
    [Abstract] [Full Text] [Related]

  • 13. Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina.
    Ogawa H, Soejima H, Takazoe K, Miyamoto S, Kajiwara I, Shimomura H, Sakamoto T, Yoshimura M, Kugiyama K, Kimura M, Yasue H.
    Angiology; 2001 Mar 15; 52(3):167-74. PubMed ID: 11269779
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A, Hulthe J, Rosengren A, Wiklund O, Wilhelmsen L.
    Clin Sci (Lond); 2001 Nov 15; 101(5):523-31. PubMed ID: 11672458
    [Abstract] [Full Text] [Related]

  • 15. Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
    Fredrikson GN, Anand DV, Hopkins D, Corder R, Alm R, Bengtsson E, Shah PK, Lahiri A, Nilsson J.
    Diabetologia; 2009 Jul 15; 52(7):1426-33. PubMed ID: 19448981
    [Abstract] [Full Text] [Related]

  • 16. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z, Mrzljak V, Turk N, Metelko Z.
    Diabetes Nutr Metab; 1999 Dec 15; 12(6):413-7. PubMed ID: 10782563
    [Abstract] [Full Text] [Related]

  • 17. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S, Hörkkö S, Miller E, Witztum JL, Palinski W.
    Arterioscler Thromb Vasc Biol; 1998 Dec 15; 18(12):1972-82. PubMed ID: 9848892
    [Abstract] [Full Text] [Related]

  • 18. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT, Wållberg-Jonsson S, Ahmed E, Rantapää-Dahlqvist S, Lefvert AK.
    Rheumatology (Oxford); 2002 Sep 15; 41(9):988-95. PubMed ID: 12209031
    [Abstract] [Full Text] [Related]

  • 19. LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers.
    Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G.
    Arterioscler Thromb; 1994 Dec 15; 14(12):1892-9. PubMed ID: 7981176
    [Abstract] [Full Text] [Related]

  • 20. Antibodies against oxidized LDL--theory and clinical use.
    Steinerová A, Racek J, Stozický F, Zima T, Fialová L, Lapin A.
    Physiol Res; 2001 Dec 15; 50(2):131-41. PubMed ID: 11522041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.